Corcept Therapeutics Incorporated (CORT)

Return on assets (ROA)

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net income	US$ in thousands	139,733	106,140	101,418	112,512	106,011
Total assets	US$ in thousands	840,553	621,517	583,430	423,756	571,731
ROA		16.62%	17.08%	17.38%	26.55%	18.54%

December 31, 2024 calculation

ROA = Net income ÷ Total assets
= $139,733K ÷ $840,553K
= 16.62%

The return on assets (ROA) for Corcept Therapeutics Incorporated has exhibited fluctuations over the five-year period from 2020 to 2024. In 2020, the ROA stood at 18.54%, indicating that the company generated $0.1854 in profit for every dollar of assets. The following year, in 2021, the ROA improved significantly to 26.55%, showcasing a more efficient utilization of assets to generate earnings.

However, in 2022, there was a decline in ROA to 17.38%, suggesting a dip in the company's profitability per unit of assets compared to the previous year. This trend continued in 2023, with a marginal decrease to 17.08% in ROA. In the most recent period of 2024, the ROA decreased further to 16.62%, reflecting a continued downward trend in asset efficiency.

Overall, while the ROA of Corcept Therapeutics Incorporated experienced fluctuations, it is important for stakeholders to closely monitor the company's asset utilization and profitability to assess its long-term financial performance and sustainability.